INS and obesity disorder: Since MSG hypothalamic lesions do not enhance food consumption (15), but lead to obesity and insulin resistance in skeletal muscle and adipose tissue (26), this effect contributes to increased plasma NEFA levels, due to increased lipid release from adipose tissue, which enhances the FA source to the liver.